First Horizon Advisors’s Ascendis Pharma A/S ASND Stock Holding History

First Horizon Advisors’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$40.6K	Buy	+235	New	+$38.3K	﹤0.01%	1121
2022 Q3	–	Sell	-19	Closed	-$2K	–	2268
2022 Q2	$2K	Buy	+19	New	+$1.79K	﹤0.01%	2062
2021 Q4	–	Sell	-5	Closed	–	–	2251
2021 Q3	$0	Hold	5	–	–	﹤0.01%	2272
2021 Q2	$0	Sell	5 -2	-29%	-$267	﹤0.01%	1962
2021 Q1	$0	Buy	+7	New	+$1.06K	﹤0.01%	1886

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

First Horizon Advisors's ASND Position: Q2 2025 in Review

First Horizon Advisors opened a new position in Ascendis Pharma A/S (ASND) in Q2 2025: 235 shares worth $40.6K. The stake represents ﹤0.01% of the portfolio and ranks #1121 among its holdings. This is a return to the name: First Horizon Advisors previously reported a position in ASND as recently as Q2 2022.

First Horizon Advisors first reported a position in ASND in Q1 2021 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold ASND as of Q2 2025.

First Horizon Advisors held 235 shares of Ascendis Pharma A/S worth $40.6K as of Q2 2025.
Ascendis Pharma A/S was a new First Horizon Advisors position in Q2 2025.
Ascendis Pharma A/S made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1121 holding.
First Horizon Advisors first reported a position in Ascendis Pharma A/S in Q1 2021 and has held it in 5 quarters since.
247 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.